Biocryst Pharmaceuticals buy Saftman
Start price
01.03.22
/
50%
€14.57
Target price
01.03.23
-
Performance (%)
-43.77%
End price
02.03.23
€8.19
Summary
This prediction ended on 02.03.23 with a price of €8.19. The BUY prediction by Saftman for Biocryst Pharmaceuticals performed very badly with a performance of -43.77%. Saftman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biocryst Pharmaceuticals | 1.542% | 1.542% | 9.480% |
iShares Core DAX® | 1.887% | 1.967% | 17.000% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% |
Comments by Saftman for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
Saftman hat das Wertpapier Biocryst Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.
In the thread Trading Biocryst Pharmaceuticals
Die von Saftman gewählte maximale Laufzeit wurde überschritten